Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-27 4:02 pm Purchase |
2023-10-20 | 13G | Tourmaline Bio, Inc. TRML |
Deep Track Capital, LP | 1,815,854 8.930% |
1,815,854 (New Position) |
Filing History |
| 2023-10-27 4:01 pm Purchase |
2023-10-19 | 13G | Tourmaline Bio, Inc. TRML |
PFIZER INC PFE |
1,272,214 6.260% |
1,272,214 (New Position) |
Filing History |
| 2023-07-06 4:32 pm Purchase |
2023-06-26 | 13G | Talaris Therapeutics, Inc. TALS |
RA Capital Management, L.P. | 233,318 5.500% |
233,318 (New Position) |
Filing History |
| 2023-04-27 2:19 pm Unchanged |
2023-04-17 | 13G | Talaris Therapeutics, Inc. TALS |
BML Investment Partners, L.P. | 218,919 5.200% |
0 (Unchanged) |
Filing History |
| 2023-04-27 10:55 am Purchase |
2023-04-17 | 13G | Talaris Therapeutics, Inc. TALS |
BML Investment Partners, L.P. | 218,919 5.200% |
218,919 (New Position) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Talaris Therapeutics, Inc. TALS |
Citadel Advisors LLC | 352,217 8.400% |
-28,947 (-7.59%) |
Filing History |
| 2022-08-09 4:02 pm Sale |
2022-07-31 | 13G | Talaris Therapeutics, Inc. TALS |
BLACKROCK INC BLK |
198,430 4.800% |
-41,116 (-17.16%) |
Filing History |
| 2022-02-28 4:03 pm Purchase |
2021-05-11 | 13D | Talaris Therapeutics, Inc. TALS |
Qiming U.S. Healthcare GP II LLC | 298,340 7.200% |
298,340 (New Position) |
Filing History |
| 2022-02-14 5:01 pm Unchanged |
2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS |
VIKING GLOBAL INVESTORS LP | 328,962 8.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 06:30 am Sale |
2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS |
Citadel Advisors LLC | 381,164 9.000% |
-222 (-0.06%) |
Filing History |
| 2022-02-11 4:24 pm Purchase |
2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS |
Blackstone Holdings II L.P. | 808,932 19.600% |
808,932 (New Position) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS |
BLACKROCK INC BLK |
239,547 5.800% |
239,547 (New Position) |
Filing History |
| 2021-05-21 4:28 pm Purchase |
2021-05-11 | 13D | Talaris Therapeutics, Inc. TALS |
Longitude Capital Partners III LLC | 322,078 7.800% |
322,078 (New Position) |
Filing History |
| 2021-05-21 4:08 pm Purchase |
2021-05-11 | 13G | Talaris Therapeutics, Inc. TALS |
Citadel Advisors LLC | 381,386 9.200% |
381,386 (New Position) |
Filing History |
| 2021-05-17 1:25 pm Purchase |
2021-05-07 | 13G | Talaris Therapeutics, Inc. TALS |
VIKING GLOBAL INVESTORS LP | 328,962 8.200% |
328,962 (New Position) |
Filing History |